5th Circ. Deals Biden A Loss in Medicare Drug Pricing Row

By Mark Payne · September 20, 2024, 6:11 PM EDT

A Fifth Circuit panel majority said that a healthcare trade association has standing to challenge the Biden administration's Medicare drug pricing program, allowing the group to sidestep agency administrative procedure and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Natl Infusion Center v. Becerra

Case Number

Court

Appellate - 5th Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

March 14, 2024

Recent Articles By Mark

September 05, 2024
Judge Rewrites 'Unfair' Missouri Abortion Ballot Language
September 05, 2024
Feds Ask Justices For 'GVR' In Abortion Guidance Case
September 04, 2024
Trade Group Urges Court To Toss FDA Lab-Test Rule
September 03, 2024
5th Circ. Grills Feds On Congress' Intent In No Surprises Act
September 03, 2024
Will Medicaid Incarceration Waivers Hit 'Cutting Room Floor'?
August 30, 2024
HHS Wins Escape From Low-Income Hospital Payment Fight
August 30, 2024
HHS Seeks Exit From Low-Income Hospital Payment Rule Suit
August 27, 2024
Docs Foggy On Abortion Laws Amid Heated Legal Battles
August 22, 2024
Texas Tells High Court It's Not Idaho '2.0' In HHS Abortion Row
August 20, 2024
Pathology Trade Group 2nd To Sue FDA Over Lab-Test Rule